Pretreatment with paricalcitol attenuates inflammation in ischemia-reperfusion injury via the up-regulation of cyclooxygenase-2 and prostaglandin E2

Cyclooxygenase-2 Deficiency Enhances Th2 Immune Responses and Impairs Neutrophil Recruitment in Hepatic Ischemia/Reperfusion Injury

(2014) T. Hamada et al.   JOURNAL OF IMMUNOLOGY

Paricalcitol prevents cisplatin-induced renal injury by suppressing apoptosis and proliferation

(2012) Jeong Woo Park et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Mechanisms of the Anti-Cancer and Anti-Inflammatory Actions of Vitamin D

(2011) Aruna V. Krishnan et al.   Annual Review of Pharmacology and Toxicology

Roles of Prostaglandin E2 in Cardiovascular Diseases

(2011) Jun-ichi Suzuki et al.   International Heart Journal

Hypoxia and Inflammation

(2011) Holger K. Eltzschig et al.   NEW ENGLAND JOURNAL OF MEDICINE

Paricalcitol attenuates cyclosporine-induced kidney injury in rats

(2010) Jeong Woo Park et al.   KIDNEY INTERNATIONAL

New Vitamin D analogs and changing therapeutic paradigms

(2010) John Cunningham et al.   KIDNEY INTERNATIONAL

Macrophages, Dendritic Cells, and Kidney Ischemia-Reperfusion Injury

(2010) Li Li et al.   SEMINARS IN NEPHROLOGY

Immune Mechanisms and Novel Pharmacological Therapies of Acute Kidney Injury

(2009) Amandeep Bajwa et al.   CURRENT DRUG TARGETS

Modulation of inflammatory response by selective inhibition of cyclooxygenase-1 and cyclooxygenase-2 in acute kidney injury

(2009) Carla Q. Feitoza et al.   INFLAMMATION RESEARCH

The innate immune response in ischemic acute kidney injury

(2008) Hye Ryoun Jang et al.   CLINICAL IMMUNOLOGY

Paricalcitol Inhibits Renal Inflammation by Promoting Vitamin D Receptor-Mediated Sequestration of NF- B Signaling

(2008) X. Tan et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Inflammation in Acute Kidney Injury

(2008) Gilbert R. Kinsey et al.   NEPHRON EXPERIMENTAL NEPHROLOGY